J2KBIO Co., Ltd. (KOSDAQ:420570)

J2KBIO Statistics

Total Valuation

J2KBIO has a market cap or net worth of KRW 49.12 billion. The enterprise value is 38.90 billion.

Market Cap	49.12B
Enterprise Value	38.90B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

J2KBIO has 5.85 million shares outstanding. The number of shares has increased by 8.57% in one year.

Current Share Class	5.85M
Shares Outstanding	5.85M
Shares Change (YoY)	+8.57%
Shares Change (QoQ)	+0.87%
Owned by Insiders (%)	62.03%
Owned by Institutions (%)	6.75%
Float	2.22M

Valuation Ratios

The trailing PE ratio is 21.67.

PE Ratio	21.67
Forward PE	n/a
PS Ratio	1.58
PB Ratio	1.49
P/TBV Ratio	1.51
P/FCF Ratio	71.90
P/OCF Ratio	26.86
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.32, with an EV/FCF ratio of 56.94.

EV / Earnings	17.31
EV / Sales	1.25
EV / EBITDA	10.32
EV / EBIT	17.00
EV / FCF	56.94

Financial Position

The company has a current ratio of 6.19, with a Debt / Equity ratio of 0.03.

Current Ratio	6.19
Quick Ratio	4.96
Debt / Equity	0.03
Debt / EBITDA	0.30
Debt / FCF	1.64
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 7.05% and return on invested capital (ROIC) is 4.26%.

Return on Equity (ROE)	7.05%
Return on Assets (ROA)	3.91%
Return on Invested Capital (ROIC)	4.26%
Return on Capital Employed (ROCE)	6.69%
Revenue Per Employee	576.38M
Profits Per Employee	41.62M
Employee Count	54
Asset Turnover	0.85
Inventory Turnover	6.24

Taxes

In the past 12 months, J2KBIO has paid 144.16 million in taxes.

Income Tax	144.16M
Effective Tax Rate	6.03%

Stock Price Statistics

The stock price has decreased by -13.31% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-13.31%
50-Day Moving Average	9,035.20
200-Day Moving Average	10,196.25
Relative Strength Index (RSI)	40.82
Average Volume (20 Days)	12,461

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, J2KBIO had revenue of KRW 31.12 billion and earned 2.25 billion in profits. Earnings per share was 387.70.

Revenue	31.12B
Gross Profit	11.87B
Operating Income	2.29B
Pretax Income	2.39B
Net Income	2.25B
EBITDA	3.77B
EBIT	2.29B
Earnings Per Share (EPS)	387.70

Balance Sheet

The company has 11.34 billion in cash and 1.12 billion in debt, giving a net cash position of 10.22 billion or 1,747.14 per share.

Cash & Cash Equivalents	11.34B
Total Debt	1.12B
Net Cash	10.22B
Net Cash Per Share	1,747.14
Equity (Book Value)	33.04B
Book Value Per Share	5,634.79
Working Capital	17.83B

Cash Flow

In the last 12 months, operating cash flow was 1.83 billion and capital expenditures -1.15 billion, giving a free cash flow of 683.18 million.

Operating Cash Flow	1.83B
Capital Expenditures	-1.15B
Free Cash Flow	683.18M
FCF Per Share	116.83

Margins

Gross margin is 38.13%, with operating and profit margins of 7.35% and 7.22%.

Gross Margin	38.13%
Operating Margin	7.35%
Pretax Margin	7.68%
Profit Margin	7.22%
EBITDA Margin	12.11%
EBIT Margin	7.35%
FCF Margin	2.19%

Dividends & Yields

This stock pays an annual dividend of 200.00, which amounts to a dividend yield of 2.38%.

Dividend Per Share	200.00
Dividend Yield	2.38%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	51.02%
Buyback Yield	-8.57%
Shareholder Yield	-6.19%
Earnings Yield	4.58%
FCF Yield	1.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

J2KBIO has an Altman Z-Score of 10.29 and a Piotroski F-Score of 4.

Altman Z-Score	10.29
Piotroski F-Score	4